Figure 3From: Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials Risk Ratios for overall survival rate of trials with or without systemic chemotherapy. Back to article page